Discover Bloomberg's 2026 Dividend Focus picks—top stocks with high yields & cash flow. See potential gainers & learn contrarian strategies.

Wondering if NovoCure at around $13 is a beaten down bargain or just a value trap? Here is a look at what the numbers are quietly saying about where the stock stands today. Despite a brutal longer ...

Every time a fire hydrant releases pressure, a water main is isolated for repair, or a city worker adjusts a buried valve ...

Subsidiary, Citius Oncology, launches cancer immunotherapy, LYMPHIR, in the U.S. in December 2025 CRANFORD, N.J., Dec. 23, 2025 /PRNewswire/ -- Citius Pharmaceuticals ...